MUKKA — Mukka Proteins Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeSmall CapNeutral

Annual income statement for Mukka Proteins, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	6,038	7,705	11,771	13,798	10,064
Cost of Revenue
Gross Profit	830	1,298	2,198	2,231	2,317
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	5,858	7,285	10,946	12,858	9,251
Operating Profit	181	420	825	940	813
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	155	360	659	875	603
Provision for Income Taxes
Net Income After Taxes	110	258	475	743	481
Minority Interest
Net Income Before Extraordinary Items
Net Income	89.8	242	441	701	465
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	89.8	242	441	701	465
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.201	0.78	1.44	2.32	1.55
Dividends per Share